The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing.
Mohammed Ahmed AkkaifNur Aizati Athirah DaudDzul Azri Mohamed NoorAbubakar Sha'abanMuhamad Ali Sk Abdul KaderBaharudin IbrahimPublished in: Cardiovascular drugs and therapy (2024)
NASM-PCR as a rapid genetic test holds promise for personalizing antiplatelet therapy in Asian CCS patients.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- patients undergoing
- end stage renal disease
- coronary artery bypass grafting
- ejection fraction
- chronic kidney disease
- newly diagnosed
- atrial fibrillation
- prognostic factors
- coronary artery
- coronary artery bypass
- genome wide
- loop mediated isothermal amplification
- heart failure
- patient reported outcomes
- left ventricular
- artificial intelligence
- transcatheter aortic valve replacement